Neuren Pharmaceutical shares are tumbling after Europe's drug gatekeeper indicated it would not approve the company's Rett syndrome therapy.

Broad, high-grade copper-gold results from Solstice Minerals at Nanadie include the best-ever grade intercept to date.

The ASX surged by lunch in the eastern states, with tech and miners leading a bounce … while the RBA decision was looming.

The ASX 200 recovered most of yesterday’s losses in a broad-based rally, resisting interest-rate-hike headwinds.

CuFe and its strategic Tennant Creek Copper Alliance partners have been awarded grants totalling $600,000 from the Northern ...

Everest Metals (ASX:EMC) has delivered a string of broad and high-grade rubidium intercepts at its Mt Edon critical minerals ...

Reporting season for the December quarter has come to an end, and these four ASX gold stocks are expecting drill results shortly.

Aura (ASX:AEE) has received firm commitments for an A$20m placement at 20.5c per share to fund development of the Tiris uranium project.

QX Resources has received firm commitments for a $1.23m placement at 0.5c per share to advance exploration at its Madaba uranium project in Tanzania.

Rick Squire’s background as a geologist helps him identify value in ASX mining stocks, with rare earths and uranium now on ...

With state-owned coal plants on the way out by 2030, WA needs to step up on its introduction of new renewable energy to meet ...

The ASX 200 started 2026 strongly to gain almost 2% in January, pushed higher by strong gains in the energy and materials ...